Ajit Ramalingam - 01 Sep 2021 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role: SVP, Chief Accounting Officer
Signature: /s/ Ajit Ramalingam
Issuer symbol: BIO
Transactions as of: 01 Sep 2021
Net transactions value: -$68,539
Form type: 4
Filing time: 03 Sep 2021, 17:07:34 UTC
Next filing: 02 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BIO	Bio-Rad A Common Stock	Options Exercise	$0	+240	+103%	$0.000000	473	02 Sep 2021	Direct	F1, F2
transaction	BIO	Bio-Rad A Common Stock	Tax liability	$68,539	-83	-18%	$825.77	390	02 Sep 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BIO	Restricted Stock Units	Award	$0	+676		$0.000000	676	01 Sep 2021	Bio-Rad A Common Stock	676	$0.000000	Direct	F3, F4
transaction	BIO	Restricted Stock Units	Options Exercise	$0	-240	-25%	$0.000000	723	02 Sep 2021	Bio-Rad A Common Stock	240	$0.000000	Direct	F3, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of Class A common stock acquired on the vesting of restricted stock units.
F2	Includes 11.7355 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2021.
F3	Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4	The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5	On September 2, 2020, the reporting person was granted 963 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.